Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
rats
100%
nervous system diseases
87%
brain
80%
blood flow
50%
mice
50%
assessments
50%
boron 7
50%
comparative evaluations
50%
rodents
50%
inhibition
50%
validation
50%
glucose
50%
doses
50%
phosphodiesterases
50%
therapy
37%
amp
27%
performance
25%
tyrosine
25%
side effects
25%
levels
25%
drugs
25%
enzymes
25%
nausea
25%
kinases
25%
transgenic mice
12%
learning
12%
plasticity
12%
receptors
12%
central nervous system
12%
curing
12%
Keyphrases
Dementia
64%
Consolidation Process
50%
Memory Consolidation
50%
7,8-Dihydroxyflavone (7,8-DHF)
50%
Rodents
50%
Selective Inhibitor
50%
GEBR-7b
50%
Cross-national Validation
50%
Cross-national Comparison
50%
Alzheimer's Disease Assessment Scale
50%
European Harmonization
50%
Phosphodiesterase 4 (PDE4)
50%
Brain-derived Neurotrophic Factor
28%
Rolipram
16%
New Drugs
16%
Inhibitory Activity
16%
Cognitive Deficits
16%
Amyloid beta
16%
Pharmacological Therapy
16%
Memory Performance
16%
Symptomatic Treatment
16%
4-methoxybenzaldehyde
16%
Main Class
16%
Nausea
16%
Beneficial Effects
14%
European Countries
12%
Geriatrics
12%
Nurse Observations
12%
CAMCOG
12%
Adaptation
12%
Neuroscience
Cyclic Adenosine Monophosphate
100%
Object Memory
62%
Memory Consolidation
60%
Phosphodiesterase Inhibitor
50%
Cyclic Guanosine Monophosphate
50%
Brain-Derived Neurotrophic Factor
50%
Emetic Agent
50%
Glucose
50%
Phosphodiesterase V
40%
Spatial Memory
32%
Rolipram
26%
Receptor Tyrosine Kinase
25%
Tyrosine Kinase
25%
Phosphodiesterase
20%
Cognitive Disorders
16%
Drug Therapy
16%
Amyloid Beta
16%
Side Effect
16%
Enzymes
16%
Neurodegeneration
12%
Agonist
12%
Neuroplasticity
12%
Alzheimer's Disease
12%
Synaptic Plasticity
12%
Neuronal Plasticity
12%
Central Nervous System
12%
Receptor
12%
Psychopathology
12%
Memory Formation
12%
Brain Function
10%